Heart Rhythm
Volume 8, Issue 8 , Pages 1214-1221, August 2011

Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy

  • Annukka M. Lahtinen, MSc

      Affiliations

    • Research Program for Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    • Department of Medicine, University of Helsinki, Helsinki, Finland
  • ,
  • Eero Lehtonen, MD, PhD

      Affiliations

    • Department of Pathology, University of Helsinki, Helsinki, Finland
    • Laboratory Animal Centre, University of Helsinki, Helsinki, Finland
  • ,
  • Annukka Marjamaa, MD, PhD

      Affiliations

    • Research Program for Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    • Department of Medicine, University of Helsinki, Helsinki, Finland
  • ,
  • Maija Kaartinen, MD, PhD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Tiina Heliö, MD, PhD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Kimmo Porthan, MD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Lasse Oikarinen, MD, PhD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Lauri Toivonen, MD, PhD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Heikki Swan, MD, PhD

      Affiliations

    • Department of Cardiology, University of Helsinki, Helsinki, Finland
  • ,
  • Antti Jula, MD, PhD

      Affiliations

    • National Institute for Health and Welfare, Helsinki, Finland
  • ,
  • Leena Peltonen, MD, PhD

      Affiliations

    • Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK
    • Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
    • The Broad Institute of MIT and Harvard, Boston, Massachusetts
    • Deceased
  • ,
  • Aarno Palotie, MD, PhD

      Affiliations

    • Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK
    • Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
    • The Broad Institute of MIT and Harvard, Boston, Massachusetts
    • Department of Medical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • ,
  • Veikko Salomaa, MD, PhD

      Affiliations

    • National Institute for Health and Welfare, Helsinki, Finland
  • ,
  • Kimmo Kontula, MD, PhD

      Affiliations

    • Research Program for Molecular Medicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
    • Department of Medicine, University of Helsinki, Helsinki, Finland
    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Kimmo Kontula, Department of Medicine, University of Helsinki, FIN-00290 Helsinki, Finland

Received 15 February 2011; accepted 3 March 2011. published online 14 March 2011.

Background

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive myocardial disorder caused by mutations of desmosomal cell adhesion proteins. The prevalence of these variants in the general population is unknown.

Objective

This study examined the spectrum and population prevalence of desmosomal mutations predisposing to ARVC in Finland.

Methods

We screened 29 Finnish ARVC probands for mutations in the DSP, DSG2, and DSC2 genes. All Finnish-type ARVC-associated mutations, including those 3 previously identified in PKP2 in the same patient group, were analyzed in the population-based Health 2000 cohort of 6,334 individuals and tested for association with electrocardiographic variables.

Results

We detected 2 novel mutations: DSG2 3059_3062delAGAG and DSP T1373A. DSG2 3059_3062delAGAG was present in a family with 5 mutation carriers. The endomyocardial samples of the DSG2 deletion carrier showed reduced immunoreactive signal for desmoglein-2, plakophilin-2, plakoglobin, and desmoplakin. DSP T1373A was found in 1 proband with typical right ventricular disease and exercise-related ventricular tachycardia. In the population sample, the collective prevalence of all 5 mutations identified in the 29 ARVC patients (PKP2 Q62K, Q59L, N613K, DSG2 3059_3062delAGAG, and DSP T1373A) was 31 of 6,334 individuals, or 0.5%. The apparent founder mutation PKP2 Q59L is present in 0.3% of Finns and was previously shown to have an approximately 20% disease penetrance.

Conclusion

One of 200 Finns carries a desmosomal mutation that may predispose to ARVC and its clinical sequelae. ARVC-associated mutations may thus be more prevalent in the population than expected based on the published ARVC prevalence data.

Keywords: Arrhythmia, Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion, Desmosome, Genetics

Abbreviations: ARVC, arrhythmogenic right ventricular cardiomyopathy, DNA, deoxyribonucleic acid, DSC2, desmocollin-2, DSG2, desmoglein-2, DSP, desmoplakin, ECG, electrocardiogram, JUP, plakoglobin, LBBB, left bundle branch block, MLPA, multiplex ligation-dependent probe amplification, PKP2, plakophilin-2, RBBB, right bundle branch block, VT, ventricular tachycardia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by research grants from the Academy of Finland to Dr. Kontula and Dr. Salomaa (grant number 129494); the Sigrid Jusélius Foundation to Dr. Kontula; the Finnish Foundation for Cardiovascular Research to Drs. Kontula, Heliö, and Porthan; the Finnish Cultural Foundation to Dr. Lahtinen; the Emil Aaltonen Foundation to Dr. Marjamaa; the Finnish Medical Foundation to Dr. Heliö; the Aarne Koskelo Foundation to Dr. Porthan; and the special governmental subsidy for health sciences research to Dr. Heliö.

PII: S1547-5271(11)00282-7

doi:10.1016/j.hrthm.2011.03.015

Heart Rhythm
Volume 8, Issue 8 , Pages 1214-1221, August 2011